National Health Investors, Inc. Plans Quarterly Dividend of $0.90 (NYSE:NHI)

National Health Investors, Inc. (NYSE:NHI - Get Free Report) announced a quarterly dividend on Tuesday, May 7th, Wall Street Journal reports. Investors of record on Friday, June 28th will be given a dividend of 0.90 per share by the real estate investment trust on Friday, August 2nd. This represents a $3.60 annualized dividend and a yield of 5.48%. The ex-dividend date of this dividend is Friday, June 28th.

National Health Investors has raised its dividend by an average of 0.9% annually over the last three years and has raised its dividend annually for the last 1 consecutive years. National Health Investors has a payout ratio of 119.6% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities analysts expect National Health Investors to earn $4.53 per share next year, which means the company should continue to be able to cover its $3.60 annual dividend with an expected future payout ratio of 79.5%.

National Health Investors Trading Up 2.2 %

Shares of NYSE:NHI traded up $1.41 on Tuesday, hitting $65.66. The company had a trading volume of 311,091 shares, compared to its average volume of 171,351. The firm's 50-day simple moving average is $60.67 and its two-hundred day simple moving average is $56.36. The firm has a market capitalization of $2.85 billion, a price-to-earnings ratio of 20.98 and a beta of 0.95. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.90. National Health Investors has a 1 year low of $48.51 and a 1 year high of $66.10.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft initiated coverage on National Health Investors in a research report on Tuesday, January 30th. They set a "buy" rating and a $69.00 price objective on the stock. StockNews.com cut National Health Investors from a "buy" rating to a "hold" rating in a research note on Thursday, April 18th. Truist Financial increased their price objective on National Health Investors from $55.00 to $58.00 and gave the stock a "hold" rating in a report on Thursday, April 4th. Wedbush boosted their target price on shares of National Health Investors from $64.00 to $66.00 and gave the company an "outperform" rating in a report on Monday, March 18th. Finally, BMO Capital Markets upgraded shares of National Health Investors from a "market perform" rating to an "outperform" rating and set a $67.00 price target for the company in a research note on Tuesday, March 12th. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $60.50.

Insider Buying and Selling at National Health Investors

In other news, Director Charlotte A. Swafford bought 10,000 shares of the company's stock in a transaction dated Tuesday, February 27th. The shares were purchased at an average price of $58.69 per share, for a total transaction of $586,900.00. Following the completion of the purchase, the director now owns 110,185 shares in the company, valued at approximately $6,466,757.65. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 8.21% of the stock is owned by company insiders.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.